Adelphi Values, Patient-Centered Outcomes, Boston, Massachusetts, USA.
Allergan Plc., Jersey City, New Jersey, USA.
Am J Gastroenterol. 2018 Jan;113(1):39-48. doi: 10.1038/ajg.2017.265. Epub 2017 Sep 19.
OBJECTIVES: The Functional Dyspepsia Symptom Diary (FDSD) was developed to address the lack of symptom-focused, patient-reported outcome (PRO) measures designed for use in functional dyspepsia (FD) patients and meeting Food and Drug Administration recommendations for PRO instrument development. METHODS: Concept elicitation interviews were conducted with FD participants to identify symptoms important and relevant to FD patients. A preliminary version of the FDSD was constructed, then completed by FD participants on an electronic device in cognitive interviews to evaluate the readability, comprehensibility, relevance, and comprehensiveness of the FDSD, and to preliminarily evaluate its measurement properties. RESULTS: During concept elicitation interviews, 45 participants spontaneously reported 19 symptom concepts. Of those, seven symptoms were selected for assessment by the eight-item FDSD. Cognitive interviews with 57 participants confirmed that participants were able to comprehend and provide meaningful responses to the FDSD, and that the handheld electronic FDSD format was suitable for use in the target population. Scores of the FDSD were well-distributed among response options, item discrimination indices suggested that the FDSD items differentiate among patients with varying degrees of FD severity, and inter-item correlations suggested that no items of the FDSD were capturing redundant information. Internal consistency estimates (0.87) and construct-related validity estimates using known-groups methods were within acceptable ranges. CONCLUSIONS: The FDSD is a content-valid PRO measure, with preliminary psychometric evidence providing support for the FDSD's items and total score. Further psychometric evaluations are recommended to more fully test the FDSD's score performance and other measurement properties in the target patient population.
目的:功能性消化不良症状日记(FDSD)的开发是为了满足缺乏针对症状的、基于患者报告的结局(PRO)测量工具的需求,这些工具是为功能性消化不良(FD)患者设计的,并符合食品和药物管理局对 PRO 工具开发的建议。
方法:对 FD 参与者进行概念启发访谈,以确定对 FD 患者重要且相关的症状。构建了 FDSD 的初步版本,然后由 FD 参与者在认知访谈中通过电子设备完成,以评估 FDSD 的可读性、可理解性、相关性和全面性,并初步评估其测量特性。
结果:在概念启发访谈中,45 名参与者自发报告了 19 个症状概念。其中,有七个症状被选入包含八项内容的 FDSD。对 57 名参与者的认知访谈证实,参与者能够理解并对 FDSD 提供有意义的回答,并且手持电子 FDSD 格式适合目标人群使用。FDSD 的评分在反应选项之间分布良好,项目区分指数表明 FDSD 项目可以区分不同严重程度的 FD 患者,项目间相关性表明 FDSD 没有项目在捕捉冗余信息。内部一致性估计值(0.87)和使用已知组方法的结构相关有效性估计值在可接受范围内。
结论:FDSD 是一种内容有效的 PRO 测量工具,初步心理测量学证据支持 FDSD 的项目和总分。建议进行进一步的心理测量学评估,以更全面地测试 FDSD 在目标患者人群中的评分表现和其他测量特性。
Neurogastroenterol Motil. 2021-9
Eur J Gastroenterol Hepatol. 2019-3
J Gastroenterol Hepatol. 2006-1
BMC Gastroenterol. 2023-9-19
Neurogastroenterol Motil. 2023-2
Am J Physiol Gastrointest Liver Physiol. 2020-2-10
Arthritis Rheumatol. 2014-5
J Neurogastroenterol Motil. 2011-10-31
Clin Pharmacol Ther. 2011-10-12
Aliment Pharmacol Ther. 2011-3-28
Gastroenterology. 2006-4